Abstract:As many small bioactive molecules fulfill their functions through interacting with protein targets, the identification of such targets is crucial in understanding their mechanisms of action (MOA) and side effects. With technological advancements in target identification, it has become possible to accurately and comprehensively study the MOA and side effects of small molecules. While small molecules with therapeutic potential were derived solely from nature in the past, the remodeling and synthesis of such molecules have now been made possible. Presently, while some small molecules have seen successful application as drugs, the majority remain undeveloped, requiring further understanding of their MOA and side effects to fully tap into their potential. Given the typical promiscuity of many small molecules and the complexity of the cellular proteome, a high‐flux and high‐accuracy method is necessary. While affinity chromatography approaches combined with MS have had successes in target identification, limitations associated with nonspecific results remain. To overcome these complications, quantitative chemical proteomics approaches have been developed including metabolic labeling, chemical labeling, and label‐free methods. These new approaches are adopted in conjunction with activity‐based protein profiling (ABPP), allowing for a rapid process and accurate results. This review will briefly introduce the principles involved in ABPP, then summarize current advances in quantitative chemical proteomics approaches as well as illustrate with examples how ABPP coupled with quantitative chemical proteomics has been used to detect the targets of drugs and other bioactive small molecules including natural products.

Biochemical Reactions in Metabolite-Protein Interaction

Methods to Profile the Macromolecular Targets of Small Compounds.

Chemoproteomic profiling of protein-metabolite interactions.

Target Identification with Quantitative Activity Based Protein Profiling (ABPP)

Protein target discovery of drug and its reactive intermediate metabolite by using proteomic strategy

Activity-based protein profiling: Recent advances in medicinal chemistry

Chemometric Identification of Canonical Metabolites Linking Critical Process Parameters to Monoclonal Antibody Production During Bioprocess Development

Chemical proteomic mapping of reversible small molecule binding sites in native systems

Chemical and Biological Strategies for Profiling Protein-Protein Interactions in Living Cells.

Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenase

Discovery of Post-Translational Modifications in Immunometabolism by Chemical Proteomics.

Quantitative Chemoproteomic Profiling with Data-Independent Acquisition-Based Mass Spectrometry

Applications of Activity-Based Protein Profiling (ABPP) and Bioimaging in Drug Discovery.

Identification of bioactive metabolites using activity metabolomics

Metabonomics and Its Role in Amino Acid Nutrition Research.

Discovery of Metabolite Biomarkers: Flux Analysis and Reaction-Reaction Network Approach

Functional metabolomics: from biomarker discovery to metabolome reprogramming

How Do Microbial Metabolites Interact with Their Protein Targets?

Chemical Proteomics to Identify Molecular Targets of Small Compounds

An efficient proteome-wide strategy for discovery and characterization of cellular nucleotide-protein interactions

Regulatory Roles of Metabolites in Cell Signaling Networks